Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Effect of Hemoglobin Level and the Vascular Reactivity Using th Generic Erythropoeitin Alpha (Renogen) on Incident Peritoneal Dialysis Patients

NCT03286712 is registered in ClinicalTrials.gov with National Kidney and Transplant Institute, Philippines as lead sponsor.

NCT NCT03286712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03286712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Effect of Hemoglobin Level and the Vascular Reactivity Using th Generic Erythropoeitin Alpha (Renogen) on Incident Peritoneal Dialysis Patients
Lead sponsor
National Kidney and Transplant Institute, Philippines
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2015
Completion date
May 31, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic kidney disease, complication of peritoneal dialysis